Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3677096012 | Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3677097015 | Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline 125 mg oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | Is a | Product containing bismuth subcitrate potassium and metronidazole and tetracycline (medicinal product) | false | Inferred relationship | Some | ||
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | biskalcitrate de bismuth | false | Inferred relationship | Some | ||
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | Has manufactured dose form | A solid single-dose form that is a shell made of gelatin or other substances. The contents of the shell may be a solid, semi-solid or liquid. | false | Inferred relationship | Some | ||
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Tetracycline (substance) | false | Inferred relationship | Some | ||
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Metronidazole (substance) | false | Inferred relationship | Some | ||
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | Has manufactured dose form | Oral dose form | false | Inferred relationship | Some | ||
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | Has manufactured dose form | Oral capsule | false | Inferred relationship | Some | ||
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | Is a | Metronidazole-containing product in oral dose form | false | Inferred relationship | Some | ||
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | Is a | Product containing tetracycline in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | This attribute specifies the numerator unit for the presentation strength of a product. | mg | false | Inferred relationship | Some | 1 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | This attribute specifies the denominator unit for the presentation strength of a product. | Capsule (unit of presentation) | false | Inferred relationship | Some | 1 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 125 | false | Inferred relationship | Some | 2 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | This attribute specifies the numerator unit for the presentation strength of a product. | mg | false | Inferred relationship | Some | 2 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | Has presentation strength denominator value | un | false | Inferred relationship | Some | 2 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | This attribute specifies the denominator unit for the presentation strength of a product. | Capsule (unit of presentation) | false | Inferred relationship | Some | 2 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 125 | false | Inferred relationship | Some | 3 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | This attribute specifies the numerator unit for the presentation strength of a product. | mg | false | Inferred relationship | Some | 3 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | Has presentation strength denominator value | un | false | Inferred relationship | Some | 3 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | This attribute specifies the denominator unit for the presentation strength of a product. | Capsule (unit of presentation) | false | Inferred relationship | Some | 3 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Tetracycline (substance) | false | Inferred relationship | Some | 1 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 125 | false | Inferred relationship | Some | 1 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | biskalcitrate de bismuth | false | Inferred relationship | Some | 2 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 140 | false | Inferred relationship | Some | 2 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Metronidazole (substance) | false | Inferred relationship | Some | 3 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Metronidazole (substance) | false | Inferred relationship | Some | 1 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Metronidazole (substance) | false | Inferred relationship | Some | 1 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | biskalcitrate de bismuth | false | Inferred relationship | Some | 3 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | biskalcitrate de bismuth | false | Inferred relationship | Some | 3 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 140 | false | Inferred relationship | Some | 3 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Tetracycline (substance) | false | Inferred relationship | Some | 2 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Tetracycline (substance) | false | Inferred relationship | Some | 2 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | Has unit of presentation | Capsule (unit of presentation) | false | Inferred relationship | Some | ||
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Tetracycline (substance) | false | Inferred relationship | Some | 1 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Metronidazole (substance) | false | Inferred relationship | Some | 3 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | biskalcitrate de bismuth | false | Inferred relationship | Some | 2 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | Is a | Product containing bismuth subcitrate potassium and metronidazole and tetracycline in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | Count of base of active ingredient | trois | false | Inferred relationship | Some | ||
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | Is a | Product containing only bismuth subcitrate potassium and metronidazole and tetracycline in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Some | ||
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Metronidazole (substance) | false | Inferred relationship | Some | 1 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | biskalcitrate de bismuth | false | Inferred relationship | Some | 3 | |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Tetracycline (substance) | false | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)